Auna (AUNA) Q4 2024: 28% FX-Neutral Adjusted EBITDA Growth Highlights Operational Leverage and Strategic Momentum

March 11, 2025 | By EarningsIQ Research

Auna delivered robust FX-neutral adjusted EBITDA growth driven by operational efficiencies and service mix optimization across its Latin American healthcare platform. Strategic partnerships in Mexico and disciplined risk management in Colombia position the company for sustainable growth despite regional headwinds. Execution on its vertically integrated model and value-based care approach underpins strong margin expansion and deleveraging progress.

Summary

• Integrated Platform Strength: Auna’s vertically and horizontally integrated model drives consistent margin expansion and operational synergies.
• Strategic Market Focus: Mexico’s oncology partnership and Peru’s mature platform anchor growth, while Colombia’s risk mitigation preserves cash flow.
• Financial Discipline: Continued deleveraging and positive adjusted net income demonstrate improving financial health amid macro uncertainties.

Business Overview

Auna operates a leading healthcare platform in Latin America with major operations in Mexico, Peru, and Colombia. The company generates revenue primarily through healthcare services and health insurance plans, including oncology-focused offerings. Its business model integrates healthcare delivery vertically and horizontally, combining hospital networks, insurance plans, and specialty services to drive efficiencies, scale, and value-based care outcomes.

Performance Analysis

Auna’s fourth quarter 2024 results showcased a 28% FX-neutral growth in adjusted EBITDA, reflecting a strong operational leverage effect from improved service mix and pricing strategies. Consolidated revenue grew 11% on an FX-neutral basis, with Mexico and Peru leading volume and pricing gains, and Colombia contributing through risk-sharing models despite regulatory challenges. Adjusted EBITDA margin expanded 3.1 percentage points year-over-year to 23.9%, underscoring the effectiveness of cost controls and network efficiencies.

The company’s full-year 2024 performance aligned with its internal 20% FX-neutral adjusted EBITDA growth target, with Peru delivering a 51% EBITDA increase and Mexico posting a 10% rise. Colombia’s EBITDA growth was more moderate at 6%, impacted by provisions related to payer interventions but partially offset by price adjustments and procurement rebates. Positive adjusted net income for four consecutive quarters and a 238 million soles improvement year-over-year signal significant earnings recovery and operational resilience.

• Segment Profitability Drivers: Mexico’s hospital network benefited from higher volumes and optimized pricing across payer tiers, driving a 30% EBITDA increase and margin expansion to 34.7% in 4Q24.
• Peru’s Mature Model: Continued growth in plan memberships and hospital service optimization fueled a 33% EBITDA rise and a 3.8-point margin improvement in the quarter.
• Colombia’s Risk Sharing: Implementation of risk-sharing contracts enhanced revenue mix and cash flow predictability, though provisions for receivables and regulatory uncertainty remain headwinds.

The company’s focus on high-complexity services and patient-centered care, alongside prudent financial management, drove leverage down to 3.6 times net debt to EBITDA, nearing its medium-term target of 3.0 times. Free cash flow generation improved significantly, supporting debt reduction and operational investments.

Executive Commentary

Strategic Positioning

1. Expansion of High-Complexity Services in Mexico

The implementation of the AUNA way in Mexico is progressing with a focus on higher complexity offerings and physician engagement. The recent five-year exclusivity agreement with Monterrey’s leading oncologists positions Auna as the reference oncology provider in the region, leveraging physician-led integration to capture a larger share of the oncology market and related ancillary services. The company is also developing OncoMexico to scale B2B and B2B2C insurance segments, expanding geographic reach through partnerships in Guadalajara, Mexico City, and Tijuana.

2. Mature and Scalable Integrated Platform in Peru

Peru remains Auna’s most mature and predictable market, delivering consistent earnings power through fully integrated healthcare and health plans businesses. Growth is driven by expanding plan memberships, optimizing hospital service flows, and increasing capacity for higher complexity procedures. Margin expansion reflects operational efficiencies and synergies achieved through network integration and pricing optimization.

3. Risk Mitigation and Cash Flow Focus in Colombia

Colombia faces ongoing regulatory and payer challenges, notably with Nueva EPS. Auna is strategically limiting exposure to high-risk payers by phasing out selected services and reallocating volumes to risk-sharing contracts with more reliable payers. This approach prioritizes cash flow stability over volume growth in the near term while maintaining the ability to capitalize on potential sector improvements in 2026 and beyond.

4. Financial Discipline and Deleveraging

Consistent EBITDA growth and improved cash generation have enabled Auna to reduce leverage to 3.6 times net debt to EBITDA. The company refinanced near-term maturities and actively manages its liability profile, positioning for further deleveraging toward a medium-term target of 3.0 times. Free cash flow exceeded interest payments in the second half of 2024, providing financial flexibility for growth investments and debt reduction.

5. Value-Based Care and Patient-Centric Model

Auna’s strategy centers on integrating data-driven decision-making, physician engagement, and patient-centered care to enhance medical resolution and optimize resource utilization. This model supports sustainable growth by improving outcomes and operational efficiency across diverse Latin American markets with varying maturity and regulatory environments.

Key Considerations

Auna’s execution reflects a nuanced balance of growth and risk management across markets with distinct dynamics.

• Seasonality Impact: Elective procedures and patient volumes typically decline in Q4 and Q1 due to holidays and deferrals, affecting sequential quarterly comparisons.
• Market Penetration Strategy: In Mexico, the company focuses on expanding high-complexity service share within existing payor pools and developing partnerships with insurers and employers to increase coverage.
• Risk Sharing Models: The adoption of risk-sharing agreements in Colombia and Mexico enhances revenue predictability but may yield slightly lower margins compared to fee-for-service models.
• OncoSalud Pricing: Oncology plan pricing is regularly adjusted for medical inflation and new therapies, maintaining stable medical loss ratios around 53%.
• Capital Allocation: Maintenance capex remains focused on infrastructure and medical equipment, supporting capacity expansion aligned with demand and integration milestones.

Risks

Regulatory interventions and payer instability in Colombia represent significant near-term risks, potentially impacting revenue growth and cash flow. The phasing out of services to Nueva EPS introduces short-term volume volatility. Currency fluctuations also affect reported results despite hedging strategies. Execution challenges in scaling complex service offerings in Mexico and expanding insurance products may delay anticipated growth. These factors warrant cautious monitoring as they could materially affect financial outcomes.

Forward Outlook

For Q1 2025, Auna anticipates continued seasonality-related softness, particularly in Mexico and Peru, with elective procedure volumes expected to remain subdued. The company maintains an internal 20% FX-neutral adjusted EBITDA growth target for 2025 but refrains from formal guidance due to uncertainties in Colombia’s payer environment.

• Focus on expanding high-complexity service volumes and insurance penetration in Mexico.
• Maintain operational efficiencies and membership growth in Peru’s integrated platform.
• Continue cautious risk exposure management and cash flow prioritization in Colombia.

Takeaways

Auna’s Q4 2024 results demonstrate the strategic value of its integrated healthcare platform in Latin America, combining operational excellence with targeted growth initiatives.

• Operational Leverage Drives Margin Expansion: Service mix optimization and pricing strategies have translated into significant EBITDA growth and margin gains across segments.
• Strategic Partnerships Enhance Market Position: The oncology exclusivity agreement in Mexico and expansion of risk-sharing models in Colombia underscore Auna’s differentiated approach to market penetration and risk management.
• Financial Health Supports Long-Term Growth: Improved leverage ratios and positive adjusted net income provide a solid foundation for continued investment and deleveraging despite external headwinds.

Conclusion

Auna's Q4 and full-year 2024 results affirm the strength and scalability of its vertically integrated healthcare platform across Latin America. While regulatory and market uncertainties persist, particularly in Colombia, the company’s focused execution on high-complexity services, strategic partnerships, and financial discipline position it well for sustainable growth and value creation.

Industry Read-Through

Auna’s performance highlights broader trends in Latin American healthcare, including the growing importance of integrated care models and risk-sharing arrangements to manage cost and quality. The company’s experience underscores the challenges posed by regulatory interventions and payer instability in emerging markets, signaling caution for peers with significant exposure to similar environments. Moreover, the emphasis on high-complexity service expansion and physician-led integration provides a blueprint for healthcare providers seeking to differentiate and scale in competitive markets.

AUNA Healthcare Healthcare Services Value-Based Care Risk Sharing Oncology Deleveraging